RYAILITI BioPharma

RYAILITI customers use both their internal data as well as various external data sources i.e., the CDC or NIH etc. These data sources often have multiple issues ranging from lack of consistency and integrity to deficiencies in standardization and the ability to integrate. This situation creates a compounded data diversity challenge. In short, it is not a ‘big data’ challenge but rather a ‘small, wide data’ challenge requiring exploration and discovery across a diverse data and process landscape.